| __timestamp | Telix Pharmaceuticals Limited | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 22622695 | 9216000000 |
| Thursday, January 1, 2015 | 24863028 | 8296000000 |
| Friday, January 1, 2016 | 21351001 | 10044000000 |
| Sunday, January 1, 2017 | 53837297 | 11560000000 |
| Monday, January 1, 2018 | 16080096 | 10558000000 |
| Tuesday, January 1, 2019 | 18525736 | 9351000000 |
| Wednesday, January 1, 2020 | 2024000 | 8933000000 |
| Friday, January 1, 2021 | 2548000 | 8284000000 |
| Saturday, January 1, 2022 | 61556000 | 7952000000 |
| Sunday, January 1, 2023 | 188157000 | 8200000000 |
| Monday, January 1, 2024 | 8480000000 |
Unleashing the power of data
In the ever-evolving pharmaceutical landscape, understanding cost structures is crucial. This analysis delves into the cost of revenue trends for Teva Pharmaceutical Industries Limited and Telix Pharmaceuticals Limited from 2014 to 2023. Over this period, Teva's cost of revenue has shown a gradual decline, dropping approximately 14% from its peak in 2017. In contrast, Telix has experienced a dramatic surge, with costs skyrocketing by over 700% from 2014 to 2023. This stark difference highlights the contrasting growth trajectories and operational strategies of these two industry players. While Teva, a well-established giant, focuses on optimizing its cost structure, Telix, a rising star, is investing heavily in scaling its operations. These insights provide a window into the strategic priorities shaping the future of these pharmaceutical companies.
Cost of Revenue Comparison: AbbVie Inc. vs Telix Pharmaceuticals Limited
Cost Insights: Breaking Down Sanofi and Telix Pharmaceuticals Limited's Expenses
Cost of Revenue: Key Insights for Gilead Sciences, Inc. and Telix Pharmaceuticals Limited
Cost of Revenue Trends: Zoetis Inc. vs Teva Pharmaceutical Industries Limited
GSK plc vs Telix Pharmaceuticals Limited: Efficiency in Cost of Revenue Explored
Analyzing Cost of Revenue: Teva Pharmaceutical Industries Limited and Corcept Therapeutics Incorporated
Cost of Revenue Comparison: Teva Pharmaceutical Industries Limited vs Cytokinetics, Incorporated
Cost Insights: Breaking Down Teva Pharmaceutical Industries Limited and Alkermes plc's Expenses
Analyzing Cost of Revenue: BioMarin Pharmaceutical Inc. and Telix Pharmaceuticals Limited
Cost of Revenue: Key Insights for Exelixis, Inc. and Telix Pharmaceuticals Limited
Comparing Cost of Revenue Efficiency: Cytokinetics, Incorporated vs Telix Pharmaceuticals Limited
Telix Pharmaceuticals Limited vs Taro Pharmaceutical Industries Ltd.: Efficiency in Cost of Revenue Explored